参考文献
|
-
Abshagen, U.,Betzien, G.,Kaufmann, B.(1982).Pharmacokinetics of metipranololin normal man.European Journal of Clinical Pharmacology,21,293-301.
-
Achari, R.,Drissel, D.,Matier, W. L.,Hulse, J. D.(1986).Metabolism and urinary excretion of esmolol in humans.Journal of Clinical Pharmacology,26(1),44-47.
-
Bernard, N.,Cuisinaud, G.,Pozet, N.(1985).Pharmacokinetics of penbutolol and its metabolites in renal insufficiency.European Journal of Clinical Pharmacology,29,215-219.
-
Buhring, K. U.,Garbe, A.(1986).Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.Journal of Chromatography,382,215-224.
-
Cerqueira, P. M.,Coelho, E. B.,Geleilete, T. J.,Goldman, G. H.,Lanchote, V. L.(2005).Influence of chronic renal failure on stereoselective metoprolol metabolism in hypertensive patients.Journal of Clinical Pharmacology,45(12),1422-1433.
-
Chu, S. Y.(1978).High-pressure liquid chromatographic determination of 8-hydroxycarteolol in plasma and urine using electrochemical detection.Journal of Pharmaceutical Sciences,67(11),1623-1625.
-
Cleaveland, C. R.,Shand, D. G.(1972).Effect of route of administration on the relationship between betaadrenergic blockade and plasma propranolol level.Clinical Pharmacology and Therapeutics,13,181-185.
-
Dreyfuss, J.,Brannick, L. J.,Vukovich, R. A.(1977).Metabolic studies in patients with nadolol: Oral and intravenous administration.Journal of Clinical Pharmacology,17,300-307.
-
Gabriel, R.,Kaye, C. M.,Sankey, M. G.(1981).Preliminary observations on the excretion of acebutolol and its acetyl metabolite in the urine and faeces of man.The Journal of Pharmacy and Pharmacology,33,386-387.
-
Gergov, M.,Robson, J. N.,Duchoslav, E.,Ojanperä, I.(2000).Automated liquid chromatographic/tandem mass spectrometric method for screening beta-blocking drugs in urine.Journal of Mass Spectrometry,35(7),912-918.
-
Gugler, R.,Herold, W.,Dengler, H. J.(1974).Pharmacokinetics of pindolol in man.European Journal of Clinical Pharmacology,7,17-24.
-
Hakusui, H.,Fujimaki, M.(1988).Pharmacokinetics of carvedilol in hypertensive patients with renal failure.Drugs,36,144-147.
-
Heel, R. C.,Brogden, R. N.,Speight, T. M.(1979).Atenolol: A review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.Drugs,17,425-460.
-
Hitzenberger, G.,Takacs, F.,Pittner, H.(1983).Pharmacokinetics of the beta-adrenergic receptor blocking agent celiprolol after single intravenous and oral administrations in man.Arzneimittel-Forschung,33,50-52.
-
Johnsson, G.,Regardh, C. G.(1976).Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clinical Pharmacokinetics,1,233-263.
-
Jun, H. W.,Hayes, S. L.,Vallner, J. J.(1979).Plasma level profiles and clinical response of penbutolol after three different single oral doses in man.Journal of Clinical Pharmacology,19,415-423.
-
Leinweber, F. J.,Szpiech, J. M.,Di Carlo, F. J.(1978).1-bunolol metabolites in human urine.Pharmacology,16(2),70-77.
-
Leopold, G.(1986).Balanced pharmacokinetics and metabolism of bisoprolol.Journal of Cardiovascular Pharmacology,8,S16-S20.
-
Martin, L. E.,Hopkins, R.,Bland, R.(1976).Metabolism of labetalol by animals and man.British Journal of Clinical Pharmacology,3,695-710.
-
Meier, J.(1977).Pindolol: A pharmacokinetic comparison with other B-adrenoreceptor blocking agents.Acta Medica Scandinavica,606,65-70.
-
Myung, S. W.,Jo, C. H.(2005).Gas chromatograph-mass spectrometric method for the determination of carvedilol and its metabolites in human urine.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences,5,70-77.
-
Nelson, W. L.,Burke, T. R., Jr.(1979).Aromatic hydroxylation of beta-adrenergic antagonists: Formation of 4'- and 5'-hydroxy-1-(isopropylamino)-3-[2'-allyloxy)phenoxy]-2-propanol from oxprenolol.Journal of Medicinal Chemistry,22(9),1082-1088.
-
Neugebauer, G.,Akpan, W.,von Mollendorff, E.(1987).Pharmacokinetics and disposition of carvedilol in humans.Journal of Cardiovascular Pharmacology,10,S85-S88.
-
Seideman, P.,Borg, K. O.,Haglund, K.(1987).Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension.British Journal of Clinical Pharmacology,23,267-271.
-
Sundquist, H.,Anttila, M. S.,Simon, A.(1979).Comparative bioavailability and pharmacokinetics of sotalol alone and in combination with hydrochlorothiazide.Journal of Clinical Pharmacology,19,557-564.
-
Tocco, D. J.,Duncan, A. E.,Delauna, F. A.(1975).Physiological disposition of and metabolism of timolol in man and laboratory animals.Drug Metabolism and Disposition: The Biological Fate of Chemicals,3,361.
-
Uematsu, T.,Kanamaru, M.,Nakashima, M.(1994).Comparative pharmacokinetic and pharmacodynamic properties of oral and intravenous (+)-sotalol in healthy volunteers.The Journal of Pharmacy and Pharmacology,46,600-605.
-
Vallner, J. J.,Jun, H. W.,Needham, T. E.(1977).Plasma level studies of penbutolol after oral dose in man.Journal of Clinical Pharmacology,17,231-236.
-
von Mollendorff, E.,Reiff, K.,Neugebauer, G.(1987).Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker.European Journal of Clinical Pharmacology,33,511-513.
-
Wang, S.,Cyronak, M.,Yang, E.(2007).Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma.Journal of Pharmaceutical and Biomedical Analysis,43(2),701-707.
-
Wong, Y. W.,Ludden, T, M.(1990).Determination of betaxolol and its metabolites in blood and urine by highperformance liquid chromatography with fluorimetric detection.Journal of Chromatography,534,161-172.
-
祈崇溥、許美智(1997)。β阻斷劑之臨床作用與藥理作用及運動表現之關係。大專體育,31,60-64。
-
許美智、詹貴惠(2005)。運動藥物學。高雄:春橋田股份有限公司。
-
楊則宜(1993)。藥物與競技體育。北京:人名體育出版社。
|